Assetmark Inc. Acquires 96 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Assetmark Inc. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,834 shares of the company’s stock after acquiring an additional 96 shares during the period. Assetmark Inc.’s holdings in HCA Healthcare were worth $746,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Terra Nova Asset Management LLC lifted its stake in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares in the last quarter. Waldron Private Wealth LLC lifted its stake in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management lifted its stake in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after buying an additional 30 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last three months. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $342.96 on Friday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company has a market capitalization of $86.87 billion, a P/E ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. The company’s 50-day simple moving average is $386.00 and its two-hundred day simple moving average is $357.03. HCA Healthcare, Inc. has a one year low of $238.82 and a one year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on HCA. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Finally, Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.